Bankrupt DNA testing company 23andMe Holding (OTC:MEHCQ) is set to hold a second auction to sell its assets, including ...

Nasdaq previously suspended the trading of 23andMe’s Class A common stock, $0.0001 par value per share (the “Common Stock”), at the opening of business on March 31, 2025 and notified the ...

On May 19, Regeneron Pharmaceuticals (NASDAQ: REGN) announced that it was the successful bidder for substantially all of 23andMe's assets, agreeing to pay $256 million for them. The deal is still ...

23andMe has said it wants to allow new bids by both parties with a deadline of 12th June, according to a Financial Times ...

Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.

Me on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange ...